Gaba Sleep Quality Randomized Trial: What the Evidence Says

Quick Answer

Gaba Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Persistent sleep disturbance is also associated with fatigue, impaired concentration, anxiety and depressive symptoms, increased health-care use, and suicidal thoughts or behaviors, although these associations are strongly shaped by medical and psychiatric comorbidity. [Ming He (2026); evidence level 3]
• Guideline documents, however, also emphasize individualized risk-benefit assessment and attention to next-day sedation, falls, tolerance, dependence, and cognitive adverse effects (;). [Ming He (2026); evidence level 3]
• This review was designed as a narrative review of the clinical and mechanistic evidence supporting Ayurvedic interventions for sleep disorders. [Vendrame Martina (2026); evidence level 4]
• Electrophysiological studies, however, may suggest that increased withanolide or withaferin A content does not induce sleep or activate GABA-A receptors. [Vendrame Martina (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For gaba sleep quality randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Ming He (2026). Acupuncture-related peripheral stimulation as a candidate neuromodulatory model of insomnia: clinical evidence, sleep-wake circuitry, and translational limits. DOI: 10.3389/fnins.2026.1884710. PMCID: PMC13557252. PMID: 42719845. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13557252/
• Vendrame Martina (2026). Ayurveda Treatments for Insomnia: A Narrative Review. DOI: 10.3390/jcm15176750. PMCID: PMC13566870. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13566870/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.